Description
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Metrics
CVSS 3.1 8.8/10
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HWeakness enumeration
Affected software
| Vendor | Product | Versions |
|---|---|---|
| Mirion Medical | EC2 Software NMIS BioDose | < 23.0 |
References
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01Third Party Advisory
Timeline
- Published
- Dec 2, 2025
- Last modified
- Sep 25, 2026
- NVD status
- Analyzed